Increased size of third ventricle in patients with multiple sclerosis and chronic cerebrospinal venous insufficiency
Authors d'Alessandro A, Mandolesi S, Niglio T, Orsini A, Di Cello P, Pelle F, Mora F, d'Alessandro A, Mandolesi D, Fedele F
Received 24 October 2013
Accepted for publication 30 April 2014
Published 17 September 2014 Volume 2014:2 Pages 91—97
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
Aldo d'Alessandro,1 Sandro Mandolesi,2 Tarcisio Niglio,6 Augusto Orsini,3 Pierfrancesco Di Cello,3–5 Fabio Pelle,5 Fabio Mora,3 Alessandro d'Alessandro,4 Dimitri Mandolesi,7 Francesco Fedele2
1Department of Angiology, T Masselli–Mascia Hospital, San Severo (FG), Italy; 2Department of Cardio-vascular and Respiratory Sciences, Nephrology and Geriatric, Sapienza University, Rome, Italy; 3Department of Vascular Surgery, Gioia Hospital, Sora (FR), Italy; 4Faculty of Medicine, Catholic University "Our Lady of Good Counsel", Tirana, Albania; 5Department of Surgery, Sapienza University, Rome, Italy; 6Istituto Superiore di Sanità, Rome, Italy; 7Medicina del Lavoro, Sapienza University, Rome, Italy
Objective: The aim of the present study was to assess the size of the third ventricle in a sample of patients with multiple sclerosis (MS) affected by chronic cerebrospinal venous insufficiency (CCSVI), versus size of the third ventricle in a healthy control group.
Background: CCSVI, a new nosological vascular pattern, has recently been associated with MS.
Methods: We enrolled 33 patients affected by MS (three in the primary progressive clinical course, 23 in the relapsing–remitting clinical course, and seven in the secondary–progressive clinical course). All patients had been affected by CCSVI and were tested using an echo color Doppler (ECD) imaging unit. The group of 33 affected by both MS and CCSVI (MS–CCSVI) was composed of 19 females and 14 males with a mean age of 40±10 years, from a minimum age of 20 years to a maximum age of 66 years, with a median of 40 years and a mode of 32 years. We compared the 33 MS–CCSVI patients with 33 healthy control subjects of similar sex and age. In the MS–CCSVI group, the MS clinical severity was expressed by expanded disability status scale (EDSS) score: light (19 patients, scoring 1, 2, or 3); medium (ten patients with a score of 4, 5, or 6), and severe (four patients with a score of 7, 8, or 9). The average duration of the MS was 10±7 years (from a minimum of 1 to a maximum of 26 years, with a median of 10 years and a mode of 1 year).
Results: In the MS–CCSVI group, the third ventricle diameter was 6.2±1.7 mm (from a minimum of 2.5 mm to a maximum of 9.2 mm, with a median of 6.3 mm, and a mode of 6.0 mm). Our data showed that 29 patients (88%) had an increase in third ventricle diameter, whereas only four patients (12%) had physiological size (less than 4 mm) comparable to all healthy control group subjects (27.28%). These results show that the increase in the third ventricle diameter could represent a criterion of positivity of neurological disease in patients with CCSVI.
Keywords: MS, CSSVI, increased size of the third ventricle
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]